substantia nigra And NotAlexandre Seillier
List of bibliographic references
Number of relevant bibliographic references: 40.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000176 | Se-Hong Oh [Corée du Sud] ; Hye-Jin Jeong [Corée du Sud] ; Jong-Min Kim [Corée du Sud] ; Dae-Hyuk Kwon [Corée du Sud] ; Sung-Yeon Park [Corée du Sud] ; Joshua H. Park [Corée du Sud] ; Young-Bo Kim [Corée du Sud] ; Je-Geun Chi [Corée du Sud] ; Chan-Woong Park [Corée du Sud] ; Beom S. Jeon [Corée du Sud] ; Zang-Hee Cho [Corée du Sud] | Quantitative analysis of the SN in Parkinson's disease implementing 3D modeling at 7.0‐T MRI |
| 000359 | Guangwei Du [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Martin Styner [États-Unis] ; Michele L. Shaffer [États-Unis] ; Suman Sen [États-Unis] ; Qing X. Yang [États-Unis] ; Xuemei Huang [États-Unis] | Combined R2* and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease |
| 000414 | N. Tambasco ; V. Belcastro [Italie] ; P. Sarchielli ; P. Floridi ; L. Pierguidi [Italie] ; C. Menichetti [Italie] ; A. Castrioto ; P. Chiarini ; L. Parnetti ; P. Eusebi [Italie] ; P. Calabresi [Italie] ; A. Rossi | A magnetization transfer study of mild and advanced Parkinson’s disease |
| 000766 | Ayse Ulusoy [Suède] ; Fabia Febbraro [Danemark] ; Poul H. Jensen [Danemark] ; Deniz Kirik [Suède] ; Marina Romero-Ramos [Suède, Danemark] | Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology |
| 000840 | C. Savio Chan [États-Unis] ; Tracy S. Gertler [États-Unis] ; D. James Surmeier [États-Unis] | A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease |
| 000A90 | Lina Shehadeh [États-Unis] ; Georgia Mitsi [États-Unis] ; Nikhil Adi [États-Unis] ; Nanette Bishopric [États-Unis] ; Spyridon Papapetropoulos [États-Unis] | Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects |
| 000B12 | M. Budisic [Croatie] ; Z. Trkanjec [Croatie] ; J. Bosnjak [Croatie] ; A. Lovrencic-Huzjan [Croatie] ; V. Vukovic [Croatie] ; V. Demarin [Croatie] | Distinguishing Parkinson’s disease and essential tremor with transcranial sonography |
| 000B53 | Helen Petrovitch [États-Unis] ; Robert D. Abbott [États-Unis, Japon] ; G. Webster Ross [États-Unis] ; James Nelson [États-Unis] ; Kamal H. Masaki [États-Unis] ; Caroline M. Tanner [États-Unis] ; Lenore J. Launer [États-Unis] ; Lon R. White [États-Unis] | Bowel movement frequency in late‐life and substantia nigra neuron density at death |
| 000C51 | Andrew Lees (neurologue) [Royaume-Uni] ; Marianna Selikhova [Royaume-Uni] ; Luiz Augusto Andrade [Brésil] ; Charles Duyckaerts [France] | The black stuff and Konstantin Nikolaevich Tretiakoff |
| 000C66 | Yoland Smith [États-Unis] ; Rosa Villalba [États-Unis] | Striatal and extrastriatal dopamine in the basal ganglia: An overview of its anatomical organization in normal and Parkinsonian brains |
| 000E25 | Michael Hutchinson [États-Unis] ; Ulrich Raff [Chili] | Detection of Parkinson's disease by MRI: Spin‐lattice distribution imaging |
| 000F18 | Andrew Lees (neurologue) [Royaume-Uni] | Unresolved issues relating to the Shaking Palsy on the celebration of James Parkinson's 250th birthday |
| 000F23 | Yu-Wen Huang [Taïwan] ; Jiann-Shing Jeng [Taïwan] ; Chung-Fen Tsai [Taïwan] ; Li-Ling Chen [Taïwan] ; Ruey-Meei Wu [Taïwan] | Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease |
| 000F25 | Uwe Walter [Allemagne] ; Dirk Dressler [Allemagne] ; Alexander Wolters [Allemagne] ; Matthias Wittstock [Allemagne] ; Reiner Benecke [Allemagne] | Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease |
| 000F27 | Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
| 000F70 | Vincent Paillé [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
| 000F75 | I. Rite [Espagne] ; S. Argüelles [Espagne] ; J. L. Venero [Espagne] ; S. García-Rodriguez [Espagne] ; A. Ayala [Espagne] ; J. Cano [Espagne] ; A. Machado [Espagne] | Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration |
| 001090 | Gerhard Ransmayr [Autriche] | Constantin von Economo's contribution to the understanding of movement disorders |
| 001121 | Masayuki Shintaku ; Kiyomitsu Oyanagi [Japon] ; Daita Kaneda | Amyotrophic lateral sclerosis with dementia showing clinical parkinsonism and severe degeneration of the substantia nigra: Report of an autopsy case |
| 001406 | Mahmoud M. Iravani [Royaume-Uni] ; Clement C. M. Leung [Royaume-Uni] ; Mona Sadeghian [Royaume-Uni] ; Claire O. Haddon [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation |
| 001416 | Pedro Barroso-Chinea [Espagne] ; Ignacio Cruz-Muros [Espagne] ; María S. Aymerich [Espagne] ; Manuel Rodríguez-Díaz [Espagne] ; Domingo Afonso-Oramas [Espagne] ; José L. Lanciego [Espagne] ; Tomás González-Hernández [Espagne] | Striatal expression of GDNF and differential vulnerability of midbrain dopaminergic cells |
| 001478 | Joanna Iczkiewicz [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Increased osteopontin expression following intranigral lipopolysaccharide injection in the rat |
| 001545 | Mahmoud M. Iravani [Royaume-Uni] ; Emilie Syed [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Louisa C. Johnston [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets |
| 001639 | Claire E. Heise [Australie] ; John Mitrofanis [Australie] | Evidence for a glutamatergic projection from the zona incerta to the basal ganglia of rats |
| 001694 | Kati Kühn ; Jennifer Wellen [Allemagne] ; Nina Link ; Lyutha Maskri ; Hermann Lübbert [Allemagne] ; Christine C. Stichel [Allemagne] | The mouse MPTP model: gene expression changes in dopaminergic neurons |
| 001747 | Carl Rosenblad [Danemark] ; Biljana Georgievska [Suède] ; Deniz Kirik [Suède] | Long‐term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system |
| 001759 | Yassine Darbaky [France] ; Claude Forni [France] ; Marianne Amalric [France] ; Christelle Baunez [France] | High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task |
| 001844 | Joseph O'Neill [États-Unis] ; Norbert Schuff [États-Unis] ; William J. Marks Jr. [États-Unis] ; Robert Feiwell [États-Unis] ; Michael J. Aminoff [États-Unis] ; Michael W. Weiner [États-Unis] | Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease |
| 001999 | David S. Rothblat [États-Unis] ; J. A. Schroeder [États-Unis] ; J. S. Schneider [États-Unis] | Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: Potential contributors to spontaneous recovery from experimental Parkinsonism |
| 001A60 | Ferda Yantiri [États-Unis] ; Anna Gasparyan [États-Unis] ; Julie K. Andersen [États-Unis] | Glutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes |
| 001C61 | Oleg V. Anichtchik [Finlande] ; Juha O. Rinne [Finlande] ; Hannu Kalimo [Finlande] ; Pertti Panula [Finlande] | An Altered Histaminergic Innervation of the Substantia Nigra in Parkinson's Disease |
| 001D25 | P. Damier ; E. C. Hirsch ; Yves Agid [France] ; A. M. Graybiel | The substantia nigra of the human brain |
| 001D42 | Claas Bentlage [Suède] ; Guido Nikkhah [Suède] ; Miles G. Cunningham [États-Unis] ; Anders Björklund [Suède] | Reformation of the Nigrostriatal Pathway by Fetal Dopaminergic Micrografts into the Substantia Nigra Is Critically Dependent on the Age of the Host |
| 001D65 | C. S. Biggs [Royaume-Uni] ; M. S. Starr [Royaume-Uni] | Microdialysis study of the effects of the antiparkinsonian drug budipine on L‐DOPA‐induced release of dopamine and 5‐hydroxytryptamine by rat substantia nigra and corpus striatum |
| 001E55 | C. S. Biggs [Royaume-Uni] ; A. Fisher [Royaume-Uni] ; M. S. Starr [Royaume-Uni] | The antiparkinsonian drug budipine stimulates the activity of aromatic L‐amino acid decarboxylase and enhances L‐DOPA‐induced dopamine release in rat substantia nigra |
| 002136 | Brigitte Piallat [France] ; Abdelhamid Benazzouz [France] ; Alim-Louis Benabid [France] | Subthalamic Nucleus Lesion in Rats Prevents Dopaminergic Nigral Neuron Degeneration After Striatal 6‐OHDA Injection: Behavioural and Immunohistochemical Studies |
| 002167 | A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
| 002692 | J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease in relation to clinical features |
| 002999 | Etienne Hirsch [France] ; Merle Ruberg [France] ; Mireille Dardenne [France] ; Marie-Madeleine Portier ; France Javoy-Agid [France] ; Jean-Francois Bach [France] ; Yves Agid [France] | monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease |
| 002A85 | François Viallet ; Elisabeth Trouche ; Daniel Beaubaton ; André Nieoullon ; Eric Legallet | Motor impairment after unilateral electrolytic lesions of the substantia nigra in baboons: Behavioral data with quantitative and kinematic analysis of a pointing movement |
| This area was generated with Dilib version V0.6.23. |  |